Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 119,180 shares at $152.11 ($18.1M) on 2021-04-20, disclosed to the SEC on 2021-04-22.
Open-market sale of $18.1M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.10 | 1,711 | $253K | 1.4% |
| 2 | $148.10 | 1,711 | $253K | 1.4% |
| 3 | $149.47 | 699 | $104K | 0.6% |
| 4 | $149.47 | 699 | $104K | 0.6% |
| 5 | $150.27 | 3,752 | $564K | 3.1% |
| 6 | $150.27 | 3,752 |
| $564K |
| 3.1% |
| 7 | $151.30 | 7,677 | $1.2M | 6.4% |
| 8 | $151.30 | 7,677 | $1.2M | 6.4% |
| 9 | $152.11 | 2,168 | $330K | 1.8% |
| 10 | $152.11 | 2,168 | $330K | 1.8% |
| 11 | $148.35 | 3,500 | $519K | 2.9% |
| 12 | $149.11 | 3,900 | $582K | 3.2% |
| 13 | $150.93 | 5,556 | $839K | 4.6% |
| 14 | $150.93 | 5,556 | $839K | 4.6% |
| 15 | $151.80 | 18,150 | $2.8M | 15.2% |
| 16 | $152.76 | 23,879 | $3.6M | 20.2% |
| 17 | $152.76 | 23,879 | $3.6M | 20.2% |
| 18 | $153.26 | 1,373 | $210K | 1.2% |
| 19 | $153.26 | 1,373 | $210K | 1.2% |
| Total | $151.66 avg | 119,180 | $18.1M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |